Asymmetrical Zirconium Metallocenes for Reverse Comonomer Distribution

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing polymerization processes struggle to produce polymers with reverse comonomer distributions and short chain branching distributions efficiently, particularly in a single reactor configuration, limiting the production of high-value polymers for applications like films.

Innovation Solution

The use of asymmetrical zirconium metallocenes with an isobutyl cyclopentadienyl ligand, which can be activated with an activator, allows for the production of polymers with reverse comonomer distributions and improved short chain branching distributions in a single reactor, leveraging the isobutyl groups to enhance C—H activation and multi-sitedness.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Manufacturing precision

If existing polymerization processes are used, then production is simplified, but reverse comonomer distribution and short chain branching distribution cannot be achieved

Engineering Contradiction:
Improvecomonomer distributionVSAvoidreactor configuration
Core Design Contradiction:
Manufacturing precisionVSDevice complexity

Solution Approach 1:

The patent employs asymmetrical zirconium metallocene catalysts with specific chiral structures (C1-symmetric or C2-symmetric configurations) to achieve reverse comonomer distribution and short chain branching distribution. The asymmetrical ligand structure creates distinct coordination environments that control monomer insertion sequences, enabling precise compositional control in a single reactor without requiring complex multi-reactor systems.

Inventive Principle:
Principle #4Asymmetry

Solution Approach 2:

The patent utilizes metallocenes with variable ligand parameters (different substituent groups R1-R6 on the cyclopentadienyl rings) to tune catalyst activity and selectivity. By changing the steric and electronic parameters of the ligand structure, the catalyst can be optimized to produce polymers with reverse comonomer distribution and broad orthogonal composition distribution while maintaining single-reactor operation.

Inventive Principle:
Principle #35Parameter changes

2Manufacturing precision

If asymmetrical zirconium metallocenes with isobutyl cyclopentadienyl ligand are used, then reverse comonomer distribution and improved short chain branching distribution are achieved, but catalyst structure complexity increases

Engineering Contradiction:
Improvecomonomer distributionVSAvoidcatalyst structure
Core Design Contradiction:
Manufacturing precisionVSDevice complexity

Solution Approach 1:

The patent employs asymmetrical zirconium metallocene catalysts with specific chiral structures (C1-symmetric or C2-symmetric configurations) to achieve reverse comonomer distribution and short chain branching distribution. The asymmetrical ligand structure creates distinct coordination environments that control monomer insertion sequences, enabling precise compositional control in a single reactor without requiring complex multi-reactor systems.

Inventive Principle:
Principle #4Asymmetry

3Productivity

If single reactor process is used, then production efficiency is improved, but reverse comonomer distribution and short chain branching distribution are difficult to achieve

Engineering Contradiction:
Improveproduction efficiencyVSAvoidcomonomer distribution
Core Design Contradiction:
ProductivityVSManufacturing precision

Solution Approach 1:

The patent employs asymmetrical zirconium metallocene catalysts with specific chiral structures (C1-symmetric or C2-symmetric configurations) to achieve reverse comonomer distribution and short chain branching distribution. The asymmetrical ligand structure creates distinct coordination environments that control monomer insertion sequences, enabling precise compositional control in a single reactor without requiring complex multi-reactor systems.

Inventive Principle:
Principle #4Asymmetry

Solution Approach 2:

The metallocene catalyst system performs multiple functions simultaneously: it controls polymerization rate, directs comonomer incorporation sequence to achieve reverse distribution, and controls short chain branching patterns. This multi-functionality in a single catalyst system enables single-reactor production of polymers with complex compositional distributions that would otherwise require multiple specialized reactors.

Inventive Principle:
Principle #6Universality (Multi-functionality)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach enables the production of polymers with broad orthogonal composition distributions and increased comonomer incorporation, achieving improved properties suitable for various applications, particularly in films, through a single reactor process.

Implementation Method 1

leveraging the isobutyl groups to enhance C—H activation and multi-sitedness

Methodology Applied
Scientific EffectC—H activation: Chemical Bonding

Implementation Method 2

polymerizing at least one olefin monomer with the asymmetrical zirconium metallocene having an isobutyl cyclopentadienyl ligand catalyst composition to make the polyolefin polymer

Methodology Applied
Scientific EffectPolymerization: Chemical Bonding

Data Source

PatentUS20250368673A1Asymmettrical zirconium metallocenes having an isobutyl cyclopentadienyl ligand
Publication Date: 2025.12.04 DOW GLOBAL TECHNOLOGIES LLC
  • US20250368673A1 patent drawing
  • US20250368673A1 patent drawing
  • US20250368673A1 patent drawing

AI summary

Embodiments of the present disclosure are directed towards asymmetrical zirconium metallocenes having an isobutyl cyclopentadienyl ligand, compositions including those asymmetrical zirconium metallocenes having an isobutyl cyclopentadienyl ligand, and methods utilizing compositions including the asymmetrical zirconium metallocenes having an isobutyl cyclopentadienyl ligand.